Endo International plc is a global specialty pharmaceutical company focused on improving patients’ lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo International is headquartered in Dublin, Ireland. U.S. headquarters are in Malvern, PA.
03/14/17Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ERPrinter Friendly Version
03/03/17Endo International plc To Delist Ordinary Shares From The Toronto Stock ExchangePrinter Friendly Version
02/28/17Endo Reports Fourth-Quarter And Full-Year 2016 Financial ResultsPrinter Friendly Version
02/24/17Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility AssurancePrinter Friendly Version
What's New
Download Documentation Corporate Fact Sheet
Download Documentation J.P. Morgan Healthcare Conference Presentation – January 9, 2017
Download Documentation Final ENDP Q3 2016 Slides
Download Documentation Informational FAQ – August 8, 2016
Download Documentation Final ENDP Q2 2016 Slides
Download Documentation Informational FAQ - May 5, 2016
Download Documentation 2015 Annual Report
Get help downloading or viewing the above file types

Investor Relations / Media Contact:
Stephen Mock
Senior Vice President, Investor Relations and Corporate Affairs
Email: mock.stephen@endo.com

Investors Relations Contact:
Nina Goworek
Senior Director, Investor Relations
Email: goworek.nina@endo.com  

Media Contact:
Heather Zoumas-Lubeski
Senior Director,
Corporate Affairs
Email: zoumaslubeski.heather@endo.com

Receive E-mail AlertsE-mail Alert Icon
You may automatically receive Endo Pharmaceuticals news and financial information by email. To choose your options for email notification, please enter your email address below and click Submit. To change your email options at any time, re-enter your email address and click Submit, then adjust your form entries.
Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts